{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:12:49Z","timestamp":1772892769177,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"NIDA","doi-asserted-by":"publisher","award":["R01 DA032701"],"award-info":[{"award-number":["R01 DA032701"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"NIDA","doi-asserted-by":"publisher","award":["ZIA DA000389"],"award-info":[{"award-number":["ZIA DA000389"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH training grant","doi-asserted-by":"publisher","award":["T32 NS 082145"],"award-info":[{"award-number":["T32 NS 082145"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH Predoctoral Training Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.neuropharm.2017.06.016","type":"journal-article","created":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T14:02:00Z","timestamp":1497621720000},"page":"410-419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Atypical dopamine transporter inhibitors R-modafinil and JHW 007 differentially affect D2 autoreceptor neurotransmission and the firing rate of midbrain dopamine neurons"],"prefix":"10.1016","volume":"123","author":[{"given":"Alicia J.","family":"Avelar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy Hauck","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Beckstead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.06.016_bib1","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1021\/jm970525a","article-title":"Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter","volume":"40","author":"Agoston","year":"1997","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib2","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1111\/ejn.13046","article-title":"A\u00a0novel dopamine transporter transgenic mouse line for identification and purification of midbrain dopaminergic neurons reveals midbrain heterogeneity","volume":"42","author":"Apuschkin","year":"2015","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib3","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.neuron.2004.05.019","article-title":"Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons","volume":"42","author":"Beckstead","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2017.06.016_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0169-328X(94)90029-9","article-title":"Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon","volume":"22","author":"Blanchard","year":"1994","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1124\/jpet.116.236000","article-title":"Modafinil activates phasic dopamine signaling in dorsal and ventral striata","volume":"359","author":"Bobak","year":"2016","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib6","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1152\/jn.00094.2012","article-title":"Methamphetamine produces bidirectional, concentration-dependent effects on dopamine neuron excitability and dopamine-mediated synaptic currents","volume":"108","author":"Branch","year":"2012","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib7","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1523\/JNEUROSCI.1395-15.2016","article-title":"Dopaminergic neurons exhibit an age-dependent decline in electrophysiological parameters in the MitoPark mouse model of Parkinson's disease","volume":"36","author":"Branch","year":"2016","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib8","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/BF00175709","article-title":"Cocaine effects in the ventral tegmental area: evidence for an indirect dopaminergic mechanism of action","volume":"342","author":"Brodie","year":"1990","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib9","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0022-3565(24)29587-2","article-title":"Electrophysiological effects of cocaethylene, cocaine, and ethanol on dopaminergic neurons of the ventral tegmental area","volume":"297","author":"Bunney","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1021\/ml1002025","article-title":"Structure-activity relationships at the monoamine transporters for a novel series of modafinil (2-[(diphenylmethyl)sulfinyl]acetamide) analogues","volume":"2","author":"Cao","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib11","doi-asserted-by":"crossref","first-page":"10676","DOI":"10.1021\/acs.jmedchem.6b01373","article-title":"Novel and high affinity 2-[(diphenylmethyl)sulfinyl]acetamide (modafinil) analogues as atypical dopamine transporter inhibitors","volume":"59","author":"Cao","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib12","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1523\/JNEUROSCI.2745-12.2012","article-title":"Species differences in somatodendritic dopamine transmission determine D2-autoreceptor-mediated inhibition of ventral tegmental area neuron firing","volume":"32","author":"Courtney","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib13","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1124\/pr.115.011668","article-title":"Evaluation of the \u201cpipeline\u201d for development of medications for cocaine use disorder: a review of translational preclinical, human laboratory, and clinical trial research","volume":"68","author":"Czoty","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib14","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1523\/JNEUROSCI.4778-04.2005","article-title":"Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine","volume":"25","author":"Desai","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1124\/jpet.113.208538","article-title":"Pharmacological characterization of a dopamine transporter ligand that functions as a cocaine antagonist","volume":"348","author":"Desai","year":"2014","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib16","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.neuroscience.2013.07.071","article-title":"Electrophysiological and amperometric evidence that modafinil blocks the dopamine uptake transporter to induce behavioral activation","volume":"252","author":"Federici","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.06.016_bib18","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1523\/JNEUROSCI.1020-10.2010","article-title":"Control of extracellular dopamine at dendrite and axon terminals","volume":"30","author":"Ford","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib19","doi-asserted-by":"crossref","first-page":"13344","DOI":"10.1523\/JNEUROSCI.3546-09.2009","article-title":"The time course of dopamine transmission in the ventral tegmental area","volume":"29","author":"Ford","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib20","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF02247379","article-title":"Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil","volume":"126","author":"Gold","year":"1996","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib21","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1523\/JNEUROSCI.09-10-03463.1989","article-title":"Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in\u00a0vitro","volume":"9","author":"Grace","year":"1989","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib22","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.npp.1301472","article-title":"Smoked cocaine self-administration is decreased by modafinil","volume":"33","author":"Hart","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.06.016_bib23","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1124\/jpet.108.145813","article-title":"Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors","volume":"329","author":"Hiranita","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib24","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1124\/jpet.113.208264","article-title":"Preclinical efficacy of N-substituted benztropine analogs as antagonists of methamphetamine self-administration in rats","volume":"348","author":"Hiranita","year":"2014","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugalcdep.2015.08.005","article-title":"A\u00a0double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence","volume":"155","author":"Kampman","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib26","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1124\/jpet.103.060525","article-title":"Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands","volume":"309","author":"Katz","year":"2004","journal-title":"J\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib27","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.biopsych.2014.03.031","article-title":"Preference for distinct functional conformations of the dopamine transporter alters the relationship between subjective effects of cocaine and stimulation of mesolimbic dopamine","volume":"76","author":"Kohut","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.06.016_bib28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1126\/science.278.5335.52","article-title":"Drug abuse: hedonic homeostatic dysregulation","volume":"278","author":"Koob","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2017.06.016_bib29","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0896-6273(00)80557-7","article-title":"Neuroscience of addiction","volume":"21","author":"Koob","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2017.06.016_bib30","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1124\/jpet.110.171629","article-title":"Dopamine transporter-dependent and -independent striatal binding of the benztropine analog JHW 007, a cocaine antagonist with low abuse liability","volume":"335","author":"Kopajtic","year":"2010","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib31","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.neuropharm.2006.09.005","article-title":"Modafinil inhibits rat midbrain dopaminergic neurons through D2-like receptors","volume":"52","author":"Korotkova","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.06.016_bib32","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00213-012-2862-2","article-title":"The stereotypy-inducing effects of N-substituted benztropine analogs alone and in combination with cocaine do not account for their blockade of cocaine self-administration","volume":"225","author":"Li","year":"2013","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1037\/1064-1297.14.1.20","article-title":"Pharmacological determinants of the reinforcing effects of psychostimulants: relation to agonist substitution treatment","volume":"14","author":"Lile","year":"2006","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib34","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1124\/mol.107.039800","article-title":"Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors","volume":"73","author":"Loland","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.biopsych.2012.03.022","article-title":"R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse","volume":"72","author":"Loland","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.06.016_bib36","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neuron.2014.08.058","article-title":"Phasic dopamine release drives rapid activation of striatal D2-receptors","volume":"84","author":"Marcott","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2017.06.016_bib37","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00213-013-3232-4","article-title":"The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders","volume":"229","author":"Mereu","year":"2013","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/ejn.13376","article-title":"The unique psychostimulant profile of (\u00b1)-modafinil: investigation of behavioral and neurochemical effects in mice","volume":"45","author":"Mereu","year":"2017","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib39","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1151\/spp05314","article-title":"The neurobiology of cocaine addiction","volume":"3","author":"Nestler","year":"2005","journal-title":"Sci. Pract. Perspect."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib40","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/med.10014","article-title":"Probes for the dopamine transporter: new leads toward a cocaine-abuse therapeutic\u2013A focus on analogues of benztropine and rimcazole","volume":"22","author":"Newman","year":"2002","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib42","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1021\/jm401754x","article-title":"Elucidation of structural elements for selectivity across monoamine transporters: novel 2-[(diphenylmethyl)sulfinyl]acetamide (modafinil) analogues","volume":"57","author":"Okunola-Bakare","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib43","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.tetasy.2004.01.039","article-title":"Synthesis and determination of the absolute configuration of the enantiomers of modafinil","volume":"15","author":"Prisinzano","year":"2004","journal-title":"Tetrahedron Asymmetry"},{"key":"10.1016\/j.neuropharm.2017.06.016_bib44","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/jpet.103.053504","article-title":"Evaluation of the blood-brain barrier transport, population pharmacokinetics, and brain distribution of benztropine analogs and cocaine using in\u00a0vitro and in\u00a0vivo techniques","volume":"307","author":"Raje","year":"2003","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.12.005","article-title":"Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter","volume":"147","author":"Reith","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib46","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1126\/science.2820058","article-title":"Cocaine receptors on dopamine transporters are related to self-administration of cocaine","volume":"237","author":"Ritz","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2017.06.016_bib47","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1471-4159.2003.02050.x","article-title":"Presynaptic regulation of dopaminergic neurotransmission","volume":"87","author":"Schmitz","year":"2003","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib48","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1124\/jpet.109.154302","article-title":"Combinations of cocaine with other dopamine uptake inhibitors: assessment of additivity","volume":"330","author":"Tanda","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib49","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1124\/jpet.109.156265","article-title":"Lack of cocaine self-administration in mice expressing a cocaine-insensitive dopamine transporter","volume":"331","author":"Thomsen","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib50","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1369-1600.2012.00458.x","article-title":"Substituting a long-acting dopamine uptake inhibitor for cocaine prevents relapse to cocaine seeking","volume":"18","author":"Vel\u00e1zquez-S\u00e1nchez","year":"2013","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib51","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.euroneuro.2010.03.005","article-title":"The high affinity dopamine uptake inhibitor, JHW 007, blocks cocaine-induced reward, locomotor stimulation and sensitization","volume":"20","author":"Vel\u00e1zquez-S\u00e1nchez","year":"2010","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib52","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.drugalcdep.2014.05.008","article-title":"Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study","volume":"141","author":"Verrico","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2017.06.016_bib53","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jama.2009.351","article-title":"Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications","volume":"301","author":"Volkow","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2017.06.016_bib54","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.biopsych.2004.12.007","article-title":"The slow and long-lasting blockade of dopamine transporters in human brain induced by the new antidepressant drug radafaxine predict poor reinforcing effects","volume":"57","author":"Volkow","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.06.016_bib55","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/npp.2011.23","article-title":"Dopamine receptor mediation of the exploratory\/hyperactivity effects of modafinil","volume":"36","author":"Young","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.06.016_bib56","series-title":"The Novel Modafinil Analog, JJC8\u2013016, as a Potential Cocaine Abuse Pharmacotherapeutic Neuropsychopharmacology","author":"Zhang","year":"2017"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817302873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817302873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T18:15:20Z","timestamp":1750356920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817302873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":55,"alternative-id":["S0028390817302873"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.06.016","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atypical dopamine transporter inhibitors R-modafinil and JHW 007 differentially affect D2 autoreceptor neurotransmission and the firing rate of midbrain dopamine neurons","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}